Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for BEAM
| Stock Name | Beam Therapeutics Inc |
| Ticker | BEAM(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US07373V1052 |
Show aggregate BEAM holdings
News associated with BEAM
- Beam Therapeutics (NASDAQ:BEAM) Earns “Buy” Rating from HC Wainwright
- Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 249.19% from the company’s previous close. A number […] - 2025-09-17 02:46:44
- Beam Therapeutics (NASDAQ:BEAM) Downgraded by Wall Street Zen to “Sell”
- Wall Street Zen lowered shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a hold rating to a sell rating in a report published on Sunday. BEAM has been the topic of several other reports. Barclays lowered their price objective on shares of Beam Therapeutics from $25.00 to $21.00 and set an “equal weight” rating […] - 2025-09-15 04:42:44
- Beam Therapeutics (NASDAQ:BEAM) Stock Rating Upgraded by Wall Street Zen
- Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other equities analysts have also commented on BEAM. Cantor Fitzgerald raised Beam Therapeutics to a “strong-buy” rating in a report on Monday, July […] - 2025-09-08 03:02:55
- Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Recommendation of “Buy” from Brokerages
- Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and three have assigned a strong buy rating to the […] - 2025-08-07 02:38:51
- Victory Capital Management Inc. Has $207,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Victory Capital Management Inc. boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 18.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,612 shares of the company’s stock after purchasing an additional 1,618 shares during the period. Victory Capital […] - 2025-08-04 05:14:52
- Bank of New York Mellon Corp Boosts Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Bank of New York Mellon Corp increased its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 14.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 318,026 shares of the company’s stock after buying an additional […] - 2025-07-24 04:27:08
- Arizona State Retirement System Boosts Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Arizona State Retirement System raised its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, Holdings Channel reports. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam Therapeutics were worth $499,000 as of […] - 2025-07-22 07:42:58
- Arizona State Retirement System Has $499,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Arizona State Retirement System boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam […] - 2025-07-22 06:57:02
- D.A. Davidson & CO. Has $1.38 Million Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- D.A. Davidson & CO. boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 37.8% in the 1st quarter, HoldingsChannel reports. The firm owned 70,857 shares of the company’s stock after acquiring an additional 19,448 shares during the period. D.A. Davidson & CO.’s holdings in Beam Therapeutics were worth $1,384,000 as of its […] - 2025-07-09 05:53:15
- QRG Capital Management Inc. Sells 870 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
- QRG Capital Management Inc. cut its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,635 shares of the company’s stock after selling 870 shares during the period. QRG […] - 2025-06-24 04:46:59
- Beam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of “Buy” by Analysts
- Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average recommendation of “Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the […] - 2025-06-23 04:48:53
- Implied ESGV Analyst Target Price: $116
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:27:28
- Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Northern Trust Corp
- Northern Trust Corp boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 7.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 740,506 shares of the company’s stock after acquiring an additional 49,415 shares during the period. Northern Trust […] - 2025-05-14 05:54:50
- Stifel Financial Corp Acquires 2,976 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
- Stifel Financial Corp boosted its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 27.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,662 shares of the company’s stock after acquiring an additional 2,976 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-14 04:56:47
- Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.8% Following Weak Earnings
- Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares traded down 6.8% during mid-day trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $18.37 and last traded at $18.47. 326,775 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 1,947,803 shares. The stock […] - 2025-05-08 02:42:51
- Dimensional Fund Advisors LP Has $38.16 Million Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Dimensional Fund Advisors LP boosted its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 24.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,538,398 shares of the company’s stock after purchasing an additional 298,067 shares during the period. Dimensional Fund Advisors […] - 2025-05-05 05:20:53
- Implied VBK Analyst Target Price: $326
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-24 08:03:06
- Beam Therapeutics Inc. (NASDAQ:BEAM) Stake Lifted by Sterling Capital Management LLC
- Sterling Capital Management LLC raised its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 816.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,409 shares of the company’s stock after buying an additional 2,146 shares during the quarter. Sterling Capital Management LLC’s holdings in Beam […] - 2025-04-24 06:31:07
- Beam Therapeutics Target of Unusually Large Options Trading (NASDAQ:BEAM)
- Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Investors acquired 10,060 put options on the company. This is an increase of approximately 1,089% compared to the typical daily volume of 846 put options. Beam Therapeutics Stock Up 3.9 % Beam Therapeutics stock opened at […] - 2025-04-24 02:30:49
- Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by LPL Financial LLC
- LPL Financial LLC grew its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.6% during the fourth quarter, Holdings Channel reports. The firm owned 27,698 shares of the company’s stock after acquiring an additional 1,462 shares during the quarter. LPL Financial LLC’s holdings in Beam Therapeutics were worth $687,000 as of […] - 2025-04-23 04:22:56
- Federated Hermes Inc. Decreases Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Federated Hermes Inc. decreased its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 20.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 29,709 shares of the company’s stock after selling 7,792 shares during the quarter. Federated Hermes Inc.’s holdings in Beam Therapeutics were worth $737,000 as of its most recent SEC filing. […] - 2025-04-17 05:16:55
- Beam Therapeutics Inc. (NASDAQ:BEAM) Holdings Decreased by Russell Investments Group Ltd.
- Russell Investments Group Ltd. cut its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 6.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 176,181 shares of the company’s stock after selling 11,664 shares during the period. Russell Investments Group Ltd.’s holdings in Beam Therapeutics were worth $4,369,000 as of its […] - 2025-04-16 05:06:53
- Geode Capital Management LLC Trims Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Geode Capital Management LLC cut its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,804,374 shares of the company’s stock after selling 3,309 shares during the quarter. Geode Capital Management […] - 2025-04-15 05:01:01
- JPMorgan Chase & Co. Sells 125,567 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
- JPMorgan Chase & Co. lowered its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 19.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513,671 shares of the company’s stock after selling 125,567 shares during the period. […] - 2025-04-14 04:36:51
- Alliancebernstein L.P. Has $5.28 Million Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Alliancebernstein L.P. lifted its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 149.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 212,804 shares of the company’s stock after purchasing an additional 127,494 shares during the quarter. Alliancebernstein L.P.’s holdings in […] - 2025-04-13 05:44:47
- KLP Kapitalforvaltning AS Makes New Investment in Beam Therapeutics Inc. (NASDAQ:BEAM)
- KLP Kapitalforvaltning AS purchased a new stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 13,400 shares of the company’s stock, valued at approximately $332,000. Other hedge funds and other institutional investors have […] - 2025-04-06 07:35:04
- Mitsubishi UFJ Asset Management Co. Ltd. Has $244,000 Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)
- Mitsubishi UFJ Asset Management Co. Ltd. lowered its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,613 shares of the company’s stock after selling 995 shares during the period. Mitsubishi UFJ Asset Management Co. […] - 2025-04-04 05:12:58
- Stocks Tumble on Weaker US Consumer Spending and Sticky Price Pressures
- The S&P 500 Index ($SPX ) (SPY ) today is down -1.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. June E-mini S&P futures (ESM25 ) are down -1.43%, and June E-mini Nasdaq futures... - 2025-03-28 18:31:32
- AlphaQuest LLC Reduces Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
- AlphaQuest LLC trimmed its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 92.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,610 shares of the company’s stock after selling 33,583 shares during the period. AlphaQuest LLC’s holdings in Beam Therapeutics […] - 2025-03-20 06:13:05
- Beam Therapeutics (NASDAQ:BEAM) Earns Overweight Rating from Cantor Fitzgerald
- Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research report issued on Wednesday,Benzinga reports. BEAM has been the subject of several other research reports. Guggenheim reaffirmed a “buy” rating and issued a $78.00 price objective on shares of Beam Therapeutics in a […] - 2025-03-14 04:44:57
iShares MSCI World Small Cap UCITS ETF USD (Acc) BEAM holdings
| Date | Number of BEAM Shares Held | Base Market Value of BEAM Shares | Local Market Value of BEAM Shares | Change in BEAM Shares Held | Change in BEAM Base Value | Current Price per BEAM Share Held | Previous Price per BEAM Share Held |
|---|
| 2025-10-15 (Wednesday) | 65,206 | USD 1,772,951 | USD 1,772,951 | | | | |
| 2025-10-10 (Friday) | 64,807 | USD 1,705,720 | USD 1,705,720 | | | | |
| 2025-10-08 (Wednesday) | 64,807 | USD 1,749,789 | USD 1,749,789 | | | | |
| 2025-10-07 (Tuesday) | 64,807 | USD 1,628,600 | USD 1,628,600 | 266 | USD -42,366 | USD 25.13 | USD 25.89 |
| 2025-10-06 (Monday) | 64,541 | USD 1,670,966 | USD 1,670,966 | 0 | USD 9,035 | USD 25.89 | USD 25.75 |
| 2025-10-03 (Friday) | 64,541 | USD 1,661,931 | USD 1,661,931 | 0 | USD 10,327 | USD 25.75 | USD 25.59 |
| 2025-10-02 (Thursday) | 64,541 | USD 1,651,604 | USD 1,651,604 | 0 | USD 94,230 | USD 25.59 | USD 24.13 |
| 2025-10-01 (Wednesday) | 64,541 | USD 1,557,374 | USD 1,557,374 | 0 | USD -9,036 | USD 24.13 | USD 24.27 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of BEAM by Blackrock for IE00BF4RFH31
Show aggregate share trades of BEAM| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 266 | | | 25.130* | | 22.24 |
| 2025-09-08 | SELL | -540 | | | 19.940* | | 22.15 Profit of 11,964 on sale |
| 2025-08-15 | BUY | 268 | | | 17.820* | | 22.18 |
| 2025-08-07 | BUY | 798 | | | 17.860* | | 22.23 |
| 2025-07-29 | BUY | 266 | | | 19.930* | | 22.33 |
| 2025-07-14 | BUY | 532 | | | 21.170* | | 22.39 |
| 2025-06-30 | BUY | 540 | | | 17.010* | | 22.48 |
| 2025-06-25 | BUY | 804 | | | 16.760* | | 22.58 |
| 2025-06-20 | SELL | -135 | | | 16.760* | | 22.69 Profit of 3,063 on sale |
| 2025-06-12 | SELL | -1,080 | | | 17.440* | | 22.92 Profit of 24,753 on sale |
| 2025-06-02 | BUY | 408 | | | 16.190* | | 23.22 |
| 2025-05-28 | BUY | 272 | | | 16.880* | | 23.37 |
| 2025-05-14 | BUY | 135 | | | 17.240* | | 23.84 |
| 2025-05-13 | BUY | 270 | | | 18.050* | | 23.88 |
| 2025-05-07 | BUY | 402 | | | 16.225* | | 24.09 |
| 2025-04-28 | BUY | 134 | | | 19.800* | | 24.38 |
| 2025-04-16 | BUY | 1,755 | | | 16.620* | | 24.81 |
| 2025-04-14 | BUY | 270 | | | 17.000* | | 24.95 |
| 2025-04-08 | SELL | -272 | | | 14.540* | | 25.32 Profit of 6,888 on sale |
| 2025-04-04 | SELL | -272 | | | 15.270* | | 25.52 Profit of 6,941 on sale |
| 2025-03-28 | BUY | 1,340 | | | 22.210* | | 25.77 |
| 2025-03-24 | BUY | 10,616 | | | 24.010* | | 25.89 |
| 2025-03-12 | SELL | -218 | | | 27.420* | | 26.05 Profit of 5,679 on sale |
| 2025-03-04 | SELL | -218 | | | 26.440* | | 26.01 Profit of 5,671 on sale |
| 2025-02-26 | SELL | -432 | | | 27.890* | | 25.98 Profit of 11,224 on sale |
| 2025-02-13 | BUY | 110 | | | 28.610* | | 25.23 |
| 2025-02-12 | BUY | 440 | | | 28.570* | | 25.18 |
| 2025-01-27 | BUY | 109 | | | 25.910* | | 24.89 |
| 2025-01-23 | BUY | 109 | | | 26.290* | | 24.84 |
| 2024-12-09 | BUY | 3,960 | | | 27.515* | | 24.62 |
| 2024-12-04 | BUY | 218 | | | 26.020* | | 24.52 |
| 2024-12-03 | BUY | 327 | | | 25.980* | | 24.49 |
| 2024-11-19 | BUY | 660 | | | 25.290* | | 23.98 |
| 2024-11-18 | BUY | 220 | | | 24.120* | | 23.98 |
| 2024-11-12 | BUY | 436 | | | 27.940* | | 23.85 |
| 2024-11-11 | BUY | 109 | | | 30.350* | | 23.42 |
| 2024-11-11 | BUY | 109 | | | 30.350* | | 23.42 |
| 2024-11-07 | BUY | 545 | | | 26.100* | | 22.93 |
| 2024-11-07 | BUY | 545 | | | 26.100* | | 22.93 |
| 2024-10-23 | BUY | 218 | | | 21.820* | | 22.94 |
| 2024-10-23 | BUY | 218 | | | 21.820* | | 22.94 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of BEAM
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 902,694 | 2,190 | 1,217,281 | 74.2% |
| 2025-09-18 | 1,122,553 | 2,189 | 1,640,607 | 68.4% |
| 2025-09-17 | 1,023,733 | 3,800 | 1,519,538 | 67.4% |
| 2025-09-16 | 874,339 | 6,127 | 1,309,367 | 66.8% |
| 2025-09-15 | 538,772 | 247 | 846,750 | 63.6% |
| 2025-09-12 | 707,896 | 1,461 | 1,138,949 | 62.2% |
| 2025-09-11 | 875,855 | 6,820 | 1,546,796 | 56.6% |
| 2025-09-10 | 584,752 | 1,614 | 920,941 | 63.5% |
| 2025-09-09 | 518,710 | 2,293 | 845,139 | 61.4% |
| 2025-09-08 | 801,507 | 531 | 1,193,473 | 67.2% |
| 2025-09-05 | 1,238,702 | 1,637 | 2,031,036 | 61.0% |
| 2025-09-04 | 900,726 | 800 | 1,465,111 | 61.5% |
| 2025-09-03 | 2,412,900 | 4,974 | 4,102,044 | 58.8% |
| 2025-09-02 | 378,279 | 147 | 620,571 | 61.0% |
| 2025-08-29 | 467,301 | 11 | 760,352 | 61.5% |
| 2025-08-28 | 548,991 | 0 | 842,799 | 65.1% |
| 2025-08-27 | 408,469 | 600 | 672,079 | 60.8% |
| 2025-08-26 | 492,314 | 0 | 682,162 | 72.2% |
| 2025-08-25 | 519,376 | 200 | 776,152 | 66.9% |
| 2025-08-22 | 441,803 | 100 | 965,144 | 45.8% |
| 2025-08-21 | 627,685 | 0 | 1,043,509 | 60.2% |
| 2025-08-20 | 809,061 | 264 | 1,230,709 | 65.7% |
| 2025-08-19 | 782,902 | 1,100 | 1,398,033 | 56.0% |
| 2025-08-18 | 556,549 | 1,394 | 1,234,385 | 45.1% |
| 2025-08-15 | 461,184 | 60 | 779,897 | 59.1% |
| 2025-08-14 | 848,848 | 36 | 1,578,760 | 53.8% |
| 2025-08-13 | 638,940 | 0 | 1,311,070 | 48.7% |
| 2025-08-12 | 670,927 | 1,455 | 1,113,551 | 60.3% |
| 2025-08-11 | 466,651 | 1,300 | 802,256 | 58.2% |
| 2025-08-08 | 323,809 | 557 | 746,123 | 43.4% |
| 2025-08-07 | 372,646 | 79 | 763,805 | 48.8% |
| 2025-08-06 | 669,329 | 41 | 1,014,663 | 66.0% |
| 2025-08-05 | 1,074,666 | 1,347 | 1,597,182 | 67.3% |
| 2025-08-04 | 529,057 | 294 | 703,681 | 75.2% |
| 2025-08-01 | 702,884 | 1,619 | 1,140,503 | 61.6% |
| 2025-07-31 | 484,476 | 234 | 942,890 | 51.4% |
| 2025-07-30 | 702,897 | 2,368 | 1,181,924 | 59.5% |
| 2025-07-29 | 557,749 | 3,448 | 868,265 | 64.2% |
| 2025-07-28 | 508,528 | 2,673 | 759,683 | 66.9% |
| 2025-07-25 | 416,991 | 1,572 | 695,006 | 60.0% |
| 2025-07-24 | 538,292 | 93 | 1,234,251 | 43.6% |
| 2025-07-23 | 503,900 | 10,095 | 1,044,035 | 48.3% |
| 2025-07-22 | 419,910 | 309 | 811,778 | 51.7% |
| 2025-07-21 | 666,924 | 3,408 | 1,264,472 | 52.7% |
| 2025-07-18 | 379,990 | 371 | 881,115 | 43.1% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.